Devon D. Kelly is an experienced professional with a robust background in biobanking, clinical operations, and genomic sciences. Currently serving as the Director of Lupus Nexus at Lupus Research Alliance since March 2022, Kelly focuses on developing an integrated infrastructure to enhance lupus drug discovery. Prior experience includes roles as Associate Director at CRISPR Therapeutics and Oregon Health and Science University, where Kelly implemented strategic initiatives in biorepository management and clinical support. Additionally, Kelly has held influential positions at GlaxoSmithKline, Paradigm Genetics, Novartis, and LabCorp, contributing significantly to sample management, forensic analysis, and molecular biology. Kelly's educational credentials include a Master of Science in Forensic Science from the University of New Haven and a Bachelor of Arts in Zoology from The George Washington University.